circle animation
circle animation
circle animation
circle animation
Neurology

CTAD 2026: 19th Clinical Trials on Alzheimer’s Disease Conference

Date: November 16-19, 2026

Location: Boston, United States

Quanterix is proud to participate in the Clinical Trials on Alzheimer’s Disease (CTAD) 2026 from November 16-19, 2026 in Boston, MA.

CTAD is a leading scientific conference focused on advancing Alzheimer’s clinical research and therapeutic development. Bringing together researchers, clinicians, industry experts, and global thought leaders, CTAD provides a collaborative platform to share cutting-edge data, discuss innovative trial designs, biomarkers, disease-modifying therapies, and translational strategies that accelerate progress toward effective treatments. Attendees will engage in plenary sessions, symposia, poster presentations, and networking opportunities aimed at shaping the future of Alzheimer’s clinical trials.

We’re excited to connect with you in Boston and explore how Quanterix can support your groundbreaking research. 

Meet Our Experts

 

Connect Beyond the Conference

 

Join Quanterix for an evening of cocktails, conversation, and connection at the historic Map Room Tea Lounge in the Boston Public Library.

When it comes to Alzheimer’s disease, some of the most important clinical decisions happen in the gray areas, where the answer is not always a clear yes or no. We’ll explore how precision biomarkers and a multi-analyte approach can help provide deeper context beyond a single test result, supporting more informed decision-making across the patient journey.

Connect with peers, exchange perspectives, and discover how emerging biomarker insights are shaping the future of Alzheimer’s disease assessment and care.

Wednesday, November 18
6:30 PM – 8:30 PM
Map Room Tea Lounge, Boston Public Library

Reserve Your Spot


Powered by Simoa®

View Details
HD-X

Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.

1000x

Up to 1000x greater sensitivity

4 in 1

Up to 4 biomarkers in a single assay

80+

Compatible with 80+ assays

View Details
SR-X

Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.

1000x

Up to 1000x greater sensitivity

4 in 1

Up to 4 biomarkers in a single assay

30+

Compatible with 30+ assays

circle animation
circle animation
circle animation
circle animation

Let us know you’d like to meet

Connect with our experts directly to take your research further.